ROBERT BRESALIER to Polymorphism, Genetic
This is a "connection" page, showing publications ROBERT BRESALIER has written about Polymorphism, Genetic.
Connection Strength
0.132
-
Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis. Semin Oncol. 2005 Dec; 32(6 Suppl 9):S11-5.
Score: 0.045
-
CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis. 2005 Jun; 26(6):1122-8.
Score: 0.043
-
CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment. Cancer Causes Control. 2013 Jan; 24(1):47-54.
Score: 0.018
-
Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial. Cancer Epidemiol Biomarkers Prev. 2009 Oct; 18(10):2726-33.
Score: 0.015
-
Hemochromatosis gene mutations and distal adenomatous colorectal polyps. Cancer Epidemiol Biomarkers Prev. 2005 Jan; 14(1):158-63.
Score: 0.011